SandyFengMD
General Surgery • San Francisco, CATransplantation
Professor, Surgery, UCSF School of Medicine
Dr. Feng is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
400 Parnassus Ave
San Francisco, CA 94143Phone+1 415-353-2318Fax+1 415-353-8917
Education & Training
Brigham and Women's HospitalResidency, Surgery, 1990 - 1995
Stanford University School of MedicineClass of 1990
Certifications & Licensure
CA State Medical License 1996 - 2025
MA State Medical License 1991 - 2002- American Board of Surgery Surgery
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
- Super Doctor SuperDoctors.com
Clinical Trials
- Withdrawal of Immunosuppression in Pediatric Liver Transplant Recipients Start of enrollment: 2006 Jun 05
- Safety and Pharmacokinetics of Ifetroban in Hepatorenal Syndrome Patients Start of enrollment: 2011 Oct 01
- Donor-Alloantigen-Reactive Regulatory T Cell (darTregs) in Liver Transplantation Start of enrollment: 2014 Dec 17
- Join now to see all
Publications & Presentations
PubMed
- 1438 citationsCharacteristics associated with liver graft failure: the concept of a donor risk index.Sandy Feng, Nathan P. Goodrich, Jennifer L. Bragg-Gresham, Dawn M. Dykstra, J. D. Punch
American Journal of Transplantation. 2006-04-01 - 202 citationsSensitization in Transplantation: Assessment of Risk (STAR) 2017 Working Group Meeting Report.Anat R. Tambur, Patricia Campbell, Frans H.J. Claas, Sandy Feng, Howard M. Gebel
American Journal of Transplantation. 2018-07-01 - 1 citationsThe Banff process-Reloaded: A joint initiative from the Banff Foundation for Allograft Pathology and the American Journal of Transplantation.Michael Mengel, Roslyn B Mannon, Sandy Feng
American Journal of Transplantation. 2024-03-01
Journal Articles
- Prevalence and Impact of De Novo DSA During a Multicenter Immunosuppression Withdrawal Trial in Adult Liver Transplant RecipientsSandy Feng, Josh Levitsky, Peter Sayre, Matthew J Everly, Abraham Shaked, Hepatology
- Instituting an Immune Tolerance Program: Hidden Challenges and Opportunities. Reply: Tolerance After Liver Transplantation: How to Implement a Program of Immune Tolera...Sandy Feng, MD, Liver transplantation
- Liver Transplants for Non‐citizens/non‐Residents: What Is the Problem and What Should Be Done?Sandy Feng, MD, American journal of transplantation
- Join now to see all
Press Mentions
FDA Panel Supports Islet Cell Treatment for Type 1 DiabetesApril 16th, 2021
Pure Red Cell Aplasia After Kidney TransplantationMay 28th, 2019- Pericardial Effusion with Necrotic Ventricular Mass in a Kidney Transplant RecipientApril 24th, 2019
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
